SCHOTT Pharma AG & Co KgaAの収益はセグメントまたは地域別にどのように分けられていますか?
SCHOTT Pharma AG & Co KgaAは収益を上げていますか?
SCHOTT Pharma AG & Co KgaAに負債はありますか?
SCHOTT Pharma AG & Co KgaAの発行済株式数は何株ですか?
主要データ
前終値
--
始値
--
当日レンジ
-
52週レンジ
-
取引高
--
平均取引高
--
1株当たり利益(TTM)
--
配当利回り
--
時価総額
--
STTPFとは何ですか?
SCHOTT Pharma AG & Co. KgaA engages in the provision of designing drug containment and drug delivery solutions. The company is headquartered in Mainz, Hessen and currently employs 4,811 full-time employees. The company went IPO on 2023-09-28. The firm is primarily engaged in designing advanced drug containment solutions and drug delivery systems for the pharmaceutical and biotech industries. The Company’s portfolio ranges from syringes and cartridges to vials and ampoules, all made using Type I Borosilicate Glass and high-grade pharmaceutical polymer.